Microvascular density, vascularendothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma

Oncology Reports

Volumn 14, Issue 1, 2005, Pages 81-84

  Ribatti, Domenico ^a   Nico, Beatrice ^a   Floris, Carlo ^b   Mangieri, Domenica ^a   Piras, Franca ^c   Ennas, Maria Grazia ^c   Vacca, Angelo ^a   Sirigu, Paola ^c  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b Oncology Hospital   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Angiogenesis; Intussusceptive microvascular growth; Melanoma; VEGF; Vessel diameter

Indexed keywords

CD31 ANTIGEN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SKIN TUMOR; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 24644432153     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Heasley DD, Toda S and Mihm MC Jr: Pathology of malignant melanoma. Surg Clin NM 76: 1223-1255, 1996. (Pubitemid 27010034)
2. Barnhill RL, Fandrey K, Levy MA, Wihm MC and Hyman B: Angiogenesis and tumor progression of melanoma: quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 67: 331-337, 1992.
3. Ribatti D, Vacca A, Palma W, Lospalluti M and Dammacco F: Angiogenesis during tumor progression in human malignant melanoma. EXS 61: 415-420, 1992.
4. Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S, et al: Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 72: 455-461, 1993. (Pubitemid 23193452)
5. Srivastava A, Laidler P, Davies RP, Horgan K and Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanomas. Am J Pathol 113: 419-423, 1998.
6. Srivastava A, Hughes LE, Woodcock JP and Laidler P: Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumor behaviour. Br J Cancer 59: 89-91, 1989. (Pubitemid 19051316)
7. Followfield ME and Cook MG: The vascularity of primary cutaneous melanoma. J Pathol 164: 241-244, 1991.
8. Straume O, Salveson HB and Aksel LA: Angiogenesis is prognostically important in vertical growth phase of melanoma. Int J Oncol 15: 595-599, 1999.
9. Kashani-Saber M, Sagebiel RW, Ferreira CMM, Nostrati M and Miller JR III: Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. J Clin Oncol 20: 1826-1831, 2002. (Pubitemid 34273272)
10. Schulze-Osthoff K, Risau W, Vollmer E and Sorg C: In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 137: 85-92, 1990. (Pubitemid 20229591)
11. Meier F, Nesbit M, Hsu MY, Martin B, Van Belle P, Elder DE, et al. Human melanoma progression in skin reconstructs: biological significance of bFGF. Am J Pathol 156: 193-200, 2000. (Pubitemid 30644452)
12. Reed JA, McNutt NS, Bogdany JK and Albino AP: Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for the melanoma progression. J Cutan Pathol 137: 85-92, 1996.
13. Bayer-Graner IB, Hough AJ and Smoller BR: Vascular endothelial growth factor in malignant melanoma: prognostic versus diagnostic uselfuness. Mod Pathol 12: 770-774, 2000.
14. Ribatti D, Vacca A, Ria R, Marzullo A, Nico B, Filotico R, et al: Neovascularization, expression of fibroblst growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer 39: 666-674, 2002. (Pubitemid 36287380)
15. Rofstad EK and Halsor EF: Vascular endothelial growth factor, interleukin-8, platelet-derived endothelial growth factor and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 60: 4932-4938, 2000.
16. Ugurel S, Rappl G, Tilgen W and Reinhold U: Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol 19: 577-83, 2000. (Pubitemid 32112873)
17. Risau W: Mechanism of angiogenesis. Nature 386: 671-674, 1997.
18. Burri PH and Tarek MR: A novel mechanism of capillary growth in the rat pulmunary microcirculation. Anat Rec 228: 33-45, 1990.
19. Patan S, Munn LL and Jain RK: Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Micro vase Res 51: 260-272, 1996.
20. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al: Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156: 1363-1380, 2000. (Pubitemid 30660013)
21. Djonov V, Andres AC and Ziemiecki A: Vascular remodeling during the normal and malignant life cycle of the mammary gland. Microsc Res Tech 52: 182-189, 2001. (Pubitemid 32107806)
22. Crivellato E, Nico B, Vacca A and Ribatti D: B-cell non-Hodgkin's lymphomas express heterogeneous patterns of neovascularization. Haematologica 88: 671-678, 2003. (Pubitemid 36781594)
23. Clark WH, Elder DE, Guerry D, Braitman LE, Trock BJ, Schulz D, et al: Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81: 1893-2004, 1989.
24. Elias H and Hyde DM: Stereological measurements of isotropic structure. In: A Guide to Pratical Stereology. Elias H and Hyde DM (eds). Basel, Karger, pp22-24, 1983.
25. Djonov V, Schimdt M, Tschanz SA and Burri PH: Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res 86: 286-292, 2000. (Pubitemid 30108822)
26. Kurz H, Burri PH and Djonov V: Angiogenesis and vascular remodeling by intussusception: from form to function. News Physiol Sci 18: 65-70, 2003. (Pubitemid 36523784)
27. Drake CJ and Little CD: VEGF and vascular fusion: implications for normal and pathological vessels. J Histochem Cytochem 74: 1351-1355, 1999.
28. Nakatsu MN, Sainson RC, Perez-del Pulgar S, Aoto JN, Aitkenhead M, Taylor KL, et al: VEGF (121) and VEGf (165) regulate blood vessel diameter through vascular endothelial growth factor receptor-2 in an in vitro angiogenesis model. Lab Invest 83: 1873-1885, 2003. (Pubitemid 38018551)
29. Breier G and Risau W: Angiogenesis in the developing brain and brain tumors. Trends Exp Med 6: 362-376, 1996.
30. Drake CJ and Little CD: Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci USA: 7657-7661, 1995.